Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories have?
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories has 44 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories published?
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories has 2023 year in the ScholarIQ index.
What is the open-access status of Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories?
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories has hybrid oa status in the ScholarIQ index.
What is the DOI of Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories?
The DOI for Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories is on the source record.
What is the PMID of Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories?
The PMID for Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories is on the source record.
What is the OpenAlex record for Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories?
The OpenAlex for Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories is on the source record.